G. V. Nekludova

ORCID: 0000-0002-9509-0867
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Thermal Regulation in Medicine
  • Long-Term Effects of COVID-19
  • Ultrasound in Clinical Applications
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 Clinical Research Studies
  • Pulmonary Hypertension Research and Treatments
  • Healthcare Systems and Public Health
  • Cystic Fibrosis Research Advances
  • Intensive Care Unit Cognitive Disorders
  • Heart Rate Variability and Autonomic Control
  • Asthma and respiratory diseases
  • Neonatal Respiratory Health Research
  • Pleural and Pulmonary Diseases
  • Cardiac Arrest and Resuscitation
  • Inhalation and Respiratory Drug Delivery
  • Phonocardiography and Auscultation Techniques
  • Ultrasound and Hyperthermia Applications
  • COVID-19 and Mental Health
  • Pneumothorax, Barotrauma, Emphysema
  • Occupational exposure and asthma
  • Respiratory viral infections research
  • Human Health and Disease
  • Non-Invasive Vital Sign Monitoring

Sechenov University
2019-2025

Federal Medical-Biological Agency
2021-2025

State Research Institute of Highly Pure Biopreparations
2019-2020

Hospital de Santa Maria
2020

Ministry of Health of the Russian Federation
2020

Incorrect inhalation technique is one of the most common reasons for ineffectiveness Chronic Obstructive Pulmonary Disease (COPD) therapy, increasing frequency exacerbations. Selection treatment based on Peak Inspiratory Flow (PIF) measurements or predictors suboptimal PIF (sPIF) could optimize therapy in patients with COPD. The goal this study was to investigate a prevalence and sPIF hospitalized acute exacerbation COPD clinical practice. involved 72 exacerbation. analysis included...

10.4046/trd.2024.0154 article EN cc-by-nc Tuberculosis & respiratory diseases 2025-03-06

Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) resulting from immune-mediated response in susceptible and sensitized individuals to a large variety of inhaled antigens. Chronic HP with fibrotic phenotype characterized by progression dismal prognosis. The aim this study was identify predictors mortality patients chronic real clinical practice.This retrospective, multicenter, observational used data registry 1355 fibrosing ILDs. included 292 diagnosed based on the...

10.3390/life13020467 article EN cc-by Life 2023-02-08

Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) that occurs in susceptible individuals response to various inhaled antigens. The fibrotic phenotype of HP characterized by progression and can lead pulmonary hypertension (PH). aim this study was estimate the prevalence PH identify predictors patients with chronic HP.

10.3390/life13061348 article EN cc-by Life 2023-06-08

Aim: To study the manifestations of COVID-19 epidemic and clinical epidemiological characteristics adult patients with a new coronavirus infection during dominance Delta SARS-COV-2 in Russian Federation. Materials Methods : Study included aged ≥18 years laboratory-confirmed diagnosis COVID-19, detected period from 09/01/2021 to 11/30/2021 (n= 2 619 298) 85 regions. Results There were periods rise decline incidence mortality spread SARS-CoV-2 Russia: June-September OctoberDecember 2021 (Wald...

10.22625/2072-6732-2024-16-3-45-55 article EN cc-by Journal Infectology 2024-09-22

Patients surviving the coronavirus disease 2019 (COVID-19) are reported to explore pulmonary sequelae. It is challenging provide function tests (PFTs) during pandemic of this contagious diseases because difficulty related infection control risks. This study aims identify important predictors lung diffusion capacity impairment in COVID-19 survivors after hospital discharge.

10.21037/jtd-24-1118 article EN Journal of Thoracic Disease 2024-11-01

Existing literature highlights the fact that patients with COVID-19 exhibit alterations in coagulation process and are associated respiratory cardiovascular diseases, including acute distress syndrome cor pulmonale. In this report, we describe effects of systemic thrombolysis on pulmonale a patient suffering from COVID-19. We demonstrated successfully improved hemodynamics our resulted prominent reduction hypercapnia, alveolar dead space, ventilatory ratio.

10.1016/j.ijid.2020.12.043 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-01-14

BACKGROUND: The COVID-19 pandemic became a challenge and caused significant social economic damage to most countries. For the objective assessment of epidemiological clinical features during different periods epidemic, studies based on large volume data patients identified throughout Russian Federation are necessary. AIM: To analyze epidemic process adult with first second rise decline in incidence Russia. MATERIALS AND METHODS: This study included aged ≥18 years confirmed diagnosis from...

10.17816/eid628868 article EN other-oa Epidemiology and Infectious Diseases 2024-04-18

Introduction. Pneumonia is a group of acute infectious (mainly bacterial) diseases various etiology, pathogenesis, and morphological characteristics characterized by focal lesions the respiratory tract lungs with obligatory presence intraalveolar exudation. Currently, wide range not only pharmacological, but also physiotherapeutic methods treatment available. Vibroacoustic therapy used to facilitate discharge bronchopulmonary secretions. Aim. To evaluate effectiveness vibroacoustic pulmonary...

10.21518/ms2024-036 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2024-05-09

Introduction . Pneumonia is a frequent manifestation of coronavirus infection. COVID-associated pneumonia disease characterized by non-standard course and number clinical phenomena that complicate timely diagnosis treatment. Aim To investigate the phenomenon mute hypoxemia in pneumonia. Materials methods The study included 214 patients who were divided into 2 groups. group with confirmed pneumonia, control interstitial lung diseases (idiopathic pulmonary fibrosis, nonspecific...

10.21518/ms2024-068 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2024-06-05

For the first time, effectiveness and safety of high doses inhaled nitric oxide (iNO) in patients with community-acquired pneumonia (CAP) has been demonstrated. The aim study was to examine adding iNO standard treatment for CAP. Methods . A pilot, single-center, prospective, randomized, open-label clinical trial conducted, which included (n = 120) hospitalized Randomization carried out using blind envelope method. Patients main group 60) received through nasal cannulas Tianox therapy device...

10.18093/0869-0189-2024-34-3-417-426 article EN cc-by-nc PULMONOLOGIYA 2024-05-27

Aim. To analyze dynamic of incidence and mortality COVID-19 clinical epidemiological characteristics adult patients with a new coronavirus infection during the early period Omicron SARS-COV-2 distribution in Russia. Materials Methods . We conducted retrospective analysis dynamics Russia until 2023. Study included aged ≥18 years laboratory-confirmed diagnosis COVID-19, detected from 01/02/2022 to 14/03/2022 (n = 3 582 688) 85 regions Participants were regardless their vaccination history....

10.31631/2073-3046-2024-23-4-116-127 article EN cc-by Epidemiology and Vaccinal Prevention 2024-09-09

Chronic respiratory failure (CRF) is the leading cause of mortality in patients with pulmonary diseases. One key treatments for CRF long-term oxygen therapy (LTOT). The main purpose LTOT to improve quality life, increase physical performance, reduce frequency exacerbations and patients. It recommended use at least 15–16 hours a day, if there no effect, this time 24 hours. Indications have remained unchanged long time. decision on appointment should be based three-fold results gas composition...

10.21518/ms2024-477 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2024-11-08
Coming Soon ...